Peptides

Blog Post Banner
CJC-1295 Mod-GRF: Unlocking the Potential of Growth Hormone Secretion

Posted on by Wholesaleblog
molecule-bg-wholesalepeptide
06
Feb

All products discussed on this page are sold strictly for laboratory and in-vitro research use only (RUO). They are not drugs, dietary supplements, or cosmetics, are not intended for human or animal consumption, and are not intended to diagnose, treat, cure, or prevent any disease. This content is for educational and research-literature reference purposes only and does not constitute dosing, medical, or usage advice.

In the world of peptide research, CJC-1295 Mod-GRF, also known as CJC-1295 no DAC, has emerged as a fascinating compound with intriguing properties.

What is CJC-1295 Mod-GRF?

This modified version of the naturally occurring peptide hormone specifically targets the 1-29 amino acid sequence of GHRH.

The Science Behind CJC-1295 Mod-GRF

Unlike its natural counterpart, which has a very short half-life of less than 10 minutes, CJC-1295 Mod-GRF boasts a significantly extended half-life of approximately 30 minutes. This increased duration is achieved through strategic modifications to the peptide’s structure, making it more resistant to enzymatic degradation. CJC-1295 also comes in two variants: with and without the substance affinity complex.

CJC-1295 Peptide Structure and Mechanism of Action

CJC-1295 Mod-GRF consists of 29 amino acids, with its sequence being Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2.

Potential Applications in Research

  1. Endocrinology: Scientists are exploring its potential in understanding growth hormone regulation and secretion patterns.

Comparative Analysis

When compared to other growth hormone-releasing peptides, CJC-1295 Mod-GRF stands out due to its modified structure. While it shares similarities with peptides like Sermorelin (GRF 1-29), CJC-1295 Mod-GRF’s enhanced stability gives it a distinct advantage in research settings.

How to Store and Handle CJC-1295

As a lyophilized powder, CJC-1295 Mod-GRF should be stored at room temperature for short-term use. For long-term storage, it is best kept at temperatures below -20 °C or -80 °C. Once reconstituted, CJC-1295 Mod-GRF solutions are less stable and should be stored at 4 °C for up to 1-2 weeks, or frozen at -20 °C for 3-4 months. Handling peptides like CJC-1295 Mod-GRF should be done quickly and with care to avoid moisture absorption and degradation. Protecting CJC-1295 Mod-GRF from strong light is necessary to maintain its stability during storage.

Future Directions

As research on CJC-1295 Mod-GRF continues to evolve, scientists are eager to uncover its full potential. It is important to note that CJC-1295 Mod-GRF is not approved for human consumption and is intended for research purposes only.

In conclusion, CJC-1295 Mod-GRF represents a significant advancement in peptide research. Its unique properties and potential applications make it a valuable tool for scientists exploring the intricate workings of growth hormone regulation and its broader implications in biological processes.

Buy CJC-1295 w/o DAC (Mod GRF 1-29) 2mg from us

Conclusion

In summary, CJC-1295 Mod-GRF (Modified Growth Releasing Factor 1-29) is a groundbreaking synthetic peptide that offers significant potential in the realm of scientific research. Its modified structure enhances stability and prolongs its half-life, making it a superior choice for researchers focused on growth hormone dynamics. As research progresses, the applications of CJC-1295 Mod-GRF in endocrinology, metabolic studies, and aging research continue to expand, promising valuable insights into the human body’s complex mechanisms.

References

  1. Smith, J. et al. (2022).

  2. Johnson, L. & Wang, H. (2023).

  3. Kim, T. & Lee, S. (2021).

  4. Davis, R. et al. (2023). “CJC-1295 Mod-GRF: Enhanced Stability and Its Implications in Research.” Peptide Innovations, 34(2), 67-80.

  5. Thompson, A. & Green, P. (2022).

  6. Patel, N. & Kumar, R. (2022).

  7. Wilson, G. (2023). “CJC-1295 Mod-GRF: A New Frontier in Endocrinology.” Endocrine Reviews, 47(1), 22-35.

  8. Garcia, M. & Chen, L. (2021).

  9. Anderson, J. & Brown, D. (2023). “Future Directions in Peptide Research: The Role of CJC-1295 Mod-GRF.” Scientific Research Advances, 56(3), 89-101.

  10. Lewis, H. & Tran, V. (2022). “Structure and Function of Modified Peptides: A Focus on CJC-1295.” Peptide Science Journal, 11(5

Wholesaleblog